Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Peripheral blood expression profile of bone morphogenetic proteins, tumor-necrosis factor-superfamily molecules and transcription factor Runx2 could be used as marker of the form of arthritis, disease activity and therapeutic responsiveness (CROSBI ID 150328)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Grčević, Danka ; Jajić, Zrinka ; Kovačić, Nataša ; Lukić, Ivan Krešimir ; Velagić, Vedran ; Grubišić, Fran ; Ivčević, Sanja ; Marušić, Ana Peripheral blood expression profile of bone morphogenetic proteins, tumor-necrosis factor-superfamily molecules and transcription factor Runx2 could be used as marker of the form of arthritis, disease activity and therapeutic responsiveness // Journal of rheumatology, 37 (2010), 2; 246-256. doi: 10.3899/jrheum.090167

Podaci o odgovornosti

Grčević, Danka ; Jajić, Zrinka ; Kovačić, Nataša ; Lukić, Ivan Krešimir ; Velagić, Vedran ; Grubišić, Fran ; Ivčević, Sanja ; Marušić, Ana

engleski

Peripheral blood expression profile of bone morphogenetic proteins, tumor-necrosis factor-superfamily molecules and transcription factor Runx2 could be used as marker of the form of arthritis, disease activity and therapeutic responsiveness

We assessed if different forms of arthritis and disease activity could be distinguished by peripheral blood expression profile of bone-regulatory factors including TNF-superfamily (TRAIL, FasL, LIGHT) and BMP-family (BMP-2, BMP-4, BMP-6) members as well as osteoblast differentiation gene Runx2. Blood cells from healthy controls (n=25) and patients with rheumatoid arthritis (RA, n=49), osteoarthritis (OA, n=17) or spondyloarthritis, including ankylosing spondylitis (AS, n=27) or psoriatic arthritis (PsA, n=23), were processed for quantitative PCR. Gene expression values were assessed in comparison with control samples, correlated with clinical data of different forms of arthritis and analyzed by ROC curves for discriminating efficiency between arthritic and control samples. BMP-4, BMP-6 and Runx2 expressions were significantly decreased in patients with RA and OA. RA patients also had decreased FasL and LIGHT expression, whereas AS patients had increased Runx2 expression. Negative correlation with disease activity variables was found for BMP-4, FasL and Runx2 in RA and for Runx2 in PsA, whereas positive correlation was found for BMP-4 in PsA. Gene expression was higher in therapy-resistant form of AS and metotrexate-treated patients in RA. ROC curve analysis confirmed discrimination between arthritic and normal samples, particularly decreased LIGHT and Runx2 for RA and increased Runx2 for AS. Our study identified BMPs and Runx2 as possible molecular biomarkers of the intensity of tissue repair in arthritis, whereas lower FasL and LIGHT indicated RA. Correlation between gene expression and disease activity may be clinically useful in assessing therapeutic effectiveness and disease monitoring.

bobe morphpgenetic proteins; tumor-necrosis factors RUNX2; gene expression; blood cells; arthritis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

37 (2)

2010.

246-256

objavljeno

0315-162X

10.3899/jrheum.090167

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost